Cyclin B1 is useful to predict occult cervical lymph node metastases in tongue carcinoma

Journal of Experimental and Clinical Cancer Research

Volumn 25, Issue 3, 2006, Pages 351-356

  Harada, Hiroyuki ^a,c   Omura, K ^a,b   Nakajima, Y ^a   Hasegawa, S ^a   Mogi, S ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b CHIBA CANCER CENTER   (Japan)

^c NONE   (Japan)

Author keywords

Cyclin B1; Occult cervical lymph node metastases; Oral tongue squamous cell carcinoma

Indexed keywords

CYCLIN B1; KI 67 ANTIGEN;

ADULT; AGED; ARTICLE; CERVICAL LYMPH NODE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABELING INDEX; LYMPH NODE METASTASIS; MALE; MITOSIS; OCCULT CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TONGUE CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CELL NUCLEUS; CYCLIN B; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECK; PROGNOSIS; SURVIVAL RATE; TONGUE NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 33751090971     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Johnson J.T., Barnes E.L., Myers E.N., Schramm V.L., Borochovitz D., Sigler B.A.: The extracapsular spread of tumors in cervical node metastases. Arch. Otolaryngol. 107: 725-729, 1981.
2. Ho C.M., Lam K.H., Wei W.I., Lau S.K., and Lam L.K.: Occult lymph node metastases in small oral tongue cancers. Head Neck 14: 359-363, 1992.
3. Capaccio P., Pruneri G., Carboni N., Pagliari A.V., Quatela M., Cesana B.M., Pignataro L.: Cyclin D1 expression is predictive of occult metastases in head and neck cancer patients with clinically negative cervical lymph nodes. Head Neck 22: 234-240, 2000.
4. Michalides R.J.: Cell cycle regulators: mechanisms and their role in aetiology, prognosis, and treatment of cancer. J. Clin. Pathol. 52: 555-568, 1999.
5. Sherr C.J.: G1 phase progression: cycling on cue. Cell 79: 551-555, 1994.
6. Kushner J., Bradley G., Young B., and Jordan RCK.: Aberrant expression of cyclin A and cyclin B1 proteins in oral carcinoma. J. Oral. Pathol. Med. 28: 77-81, 1999.
7. Norbury C., and Nurse P.: Animal cell cycles and their control. Annu. Rev. Biochem. 61: 441-470, 1992.
8. Pines J. and Hunter T.: The differential localization of human cyclins A and B is due to a cytoplasmic retention signal in cyclin B. EMBO J. 13: 3772-3781, 1994.
9. Kawamoto H., Koizumi H., Uchikoshi T.: Expression of the G2-M checkpoint regulators cyclin B1 and cdc2 in nonmalignant and malignant human breast lesions: immunocytochemical and quantitative image analyses. Am. J. Pathol. 150: 15-23, 1997.
10. Wang A., Yoshimi N., Ino N., Tanaka T., and Mori H.: Overexpression of cyclin B1 in human colorectal cancers. J. Cancer. Res. Clin. Oncol. 123: 124-127, 1997.
11. Mashal R.D., Lester S, Corless C., Richie J.P., Chandra R., Propert K.J., and Dutta A.: Expression of cell cycle-regulated proteins in prostate cancer. Cancer Res. 56: 4159-4163, 1996.
12. Takeno S., Noguchi T., Kikuchi R., Uchida Y., Yokoyama S., and Muller W.: Prognostic value of cyclin B1 in patients with esophageal squamous cell carcinoma. Cancer 94: 2874-2881, 2002.
13. Girod S.C., Krueger G., and Pape H.D.: p53 and Ki-67 expression in preneoplastic and neoplastic lesions of the oral mucosa. Int. J. Oral. Maxillofac. Surg. 22: 285-288, 1993.
14. Warnakulasuriya K.A., and Johnson N.W.: Association of overexpression of p53 oncoprotein with the state of cell proliferation in oral carcinoma. J. Oral. Pathol. Med. 23: 246-250, 1994.
15. van Diest P.J., Brugal G., and Baak J.: Proliferation markers in tumors; interpretation and clinical value. J. Clin. Pathol. 51: 716-724, 1998.
16. De Vicente J.C., Herrero-Zapatero A., Fresno M.F., Lopez-Arranz J.S.: Expression of cyclin D1 and Ki-67 in squamous cell carcinoma of the oral cavity: clinicopathological and prognostic significance. Oral. Oncol. 38: 301-308, 2002.
17. Bruno S., Dazynkiewiez Z.: Cell cycle dependent expression and stability of the nuclear antigen detected by Ki-67 antibody in HL60 cells. Cell. Prolif. 25: 31-40, 1992.
18. Anneroth G., Batsakis J., Luna M.: Review of the literature and a recommended system of malignant grading in oral squamous cell carcinomas. Scans. J. Dent. Res. 95: 229-249, 1987.
19. Soria J.C., Jang S.J., Khuri F.R., Hassan K., Liu D., Hong W.K., and Mao L.: Overexpression of cyclin BI in early-stage non-small cell lung cancer and its clinical implication. Cancer Res. 2000; 60: 4000-4004.
20. Sherr C.J.: Cancer cell cycle. Science 274: 1672-1677, 1996.
21. Hagting A., Karlsson C., Clute P., Jackman M., and Pines J.: MPF localization is controlled by nuclear export. EMBO J. 17:4127-4138, 1998.
22. De Souzaa C.P., Ellem K.A., and Gabrielli B.G:. Centrosomal and cytoplasmic Cdc2/cyclin B1 activation precedes nuclear mitotic events. Exp. Cell Res. 257: 11-21, 2000.
23. Hassan K.A., El-Naggar A.K., Soria J.C., Lie D., Hong W.K. and Mao L.: Clinical significance of cyclin B1 protein expression in squamous cell carcinoma of the tongue. Clin. Cancer Res. 7:2458-2462, 2001.
24. Dong Y., Sui L., Watanabe Y., Sugimoto K., Tokuda M.: Clinical relevance of cyclin B1 overexpression in laryngeal squamous cell carcinoma. Cancer letters 177: 13-19, 2002.
25. Nakamura N., Yamamoto H., Yao T., Oda Y., Nishiyama K., Imamura M., Yamada T., Nawata H., Tsuneyoshi H.: Prognostic significance of expressions of cell-cycle regulatory proteins in gastrointestinal stromal tumor and the relevance of the risk grade. Human Pathology 36: 828-837, 2005.